Abstract introduction the primary objective of this study was to assess response to plasma exchange plex in myasthenia gravis mg. Myasthenia gravis mg is the best example of a condition which can be successfully treated using plasmapheresis in addition to oral medications. Therefore, we conclude that plasmapheresis should be considered as a coadjuvant to thymectomy in the treatment of myasthenia gravis. Summary myasthenia gravis mg is characterized by an alteration in nervemuscle transmission due to an. Carvalho asr, silva av, ortensi fmf, fontes sv, oliveira asb. Protocolo clinico e diretrizes terapeuticas miastenia gravis. Pdf plasmapheresis in the treatment of myasthenia gravis. Pdf to study the effects of plasmapheresis in preparation for thymectomy, two. Miastenia, grave, causa, sintoma, tratamento miastenia. Refarat imunologimyasthenia gravis maret 2015 myasthenia gravis. Pdf plasmapheresis as preparatory method for thymectomy in. Extended thymectomy for treating patients with myasthenia gravis mg.
Pdf we analyzed the experience of unicamp clinical hospital with plasma. Myasthenia gravis thymus centro hospitalar do porto. Myastenia gravis miastenia grave amilton antunes barreira depto. Qual o papel da cirurgia no tratamento da miastenia grave. Plasmapheresis in the treatment of myasthenia gravis. Propomonos analisar suas indicacoes no ambito da neurologia. Plasmapheresis as preparatory method for thymectomy in.
The exact cause of mg is not known, but it is known that certain antibodies present in the patients plasma cause interference at the nervemuscle junction. Myasthenia gravis mg is a disease of the neuromuscular junction characterized by weakness. Fisiopatologia e tratamento da miastenia gravis maio 2012 3 2. Myasthenia gravis is an autoantibodymediated, neuromuscular junction disease, and is usually associated with thymic abnormalities presented as thymic tumors 10% or hyperplastic thymus 65%. Myasthenia gravis mg is the most commonly encountered autoimmune disease of the neuromuscular junction with an estimated worldwide prevalence between 15 and 179 per million people. Excellent response to therapeutic plasma exchange in myasthenia. Sheila castrosuarez 1,2,a, cesar caparozamalloa1, 3,a, maria mezavega1,4,a,b. Nos ultimos anos, a compreensao da fisiopatologia da transmissao neuromuscular tnm e da natureza da doenca proporcionou melhor tratamento com baixa mortalidade, tornando o termo mg quase injustificavel 15. Myasthenia gravis thymus complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status maria i.
290 1185 1611 783 498 1383 556 716 1264 449 676 492 1371 249 546 1433 311 1003 744 17 188 420 1025 1344 270 1086 1268 4 1327